发明名称 STEROL-O-ACYLTRANSFERASE INHIBITOR
摘要 <P>PROBLEM TO BE SOLVED: To provide an SOAT expression inhibitor, as SOAT is also called ACAT (acyl CoA: cholesterol acyl transferase), the existence of SOAT1 and SOAT2 have been known until now, SOAT1 is strongly expressed in almost all tissues, especially in macrophages, and SOAT2 is principally expressed in the liver and the intestines, i.e., to provide a preventive/therapeutic agent for various disease states such as arteriosclerosis caused by dyslipidemia by solving the dyslipidemia. <P>SOLUTION: An SOAT expression inhibitor containing a guar gum decomposition product is provided. Preferably, the SOAT expression inhibitor in which the average molecular weight of the guar gum decomposition product is 5&times;10<SP POS="POST">2</SP>-1.8&times;10<SP POS="POST">5</SP>is also provided. <P>COPYRIGHT: (C)2012,JPO&INPIT
申请公布号 JP2012162483(A) 申请公布日期 2012.08.30
申请号 JP20110023600 申请日期 2011.02.07
申请人 TAIYO KAGAKU CO LTD 发明人 YASUKAWA ZENTA;TOKUNAGA MAKOTO;ISHIHARA NORIYUKI;TAKAGI TOMOHISA;NAITO YUJI
分类号 A61K31/736;A61K31/22;A61K31/702;A61P3/06;A61P9/10;A61P43/00;C07H3/06;C08B37/00 主分类号 A61K31/736
代理机构 代理人
主权项
地址
您可能感兴趣的专利